2021/05/10 ALA-1000 Receive notice of patent allowance from Innovation, Science and Economic Development Canada (ISED), Application No.3,033,046Post author:alarpharmPost published:8 . 6 . 2021Post category:Media releases You Might Also Like 2024/03/14 ALA-3000 has received a notice of allowance from National Office of Intellectual Property of Vietnam (NOIP) after examination. (Patent Application No. 1-2021-03276) 15 . 3 . 2024 2022/08/10 ALA-1000 Received notice of patent allowance from National Institute of Industrial Property Institute (INAPI), Chile , Application No. 624-2019 11 . 8 . 2022 2022/01/13 Alar Announces Significant Progress on Developing Long-acting Buprenorphine Injectable ALA-1000 14 . 1 . 2022 2020/07/22 ALA -1000 Receive notice of patent allowance from the Mexican Institute of Industrial Property (IMPI) 13 . 8 . 2020 2024/02/22 ALA-3000 has received a notice of allowance from United States Patent and Trademark Office (USPTO) after examination. (Patent Application No. 17/421,407) 29 . 2 . 2024
2024/03/14 ALA-3000 has received a notice of allowance from National Office of Intellectual Property of Vietnam (NOIP) after examination. (Patent Application No. 1-2021-03276) 15 . 3 . 2024
2022/08/10 ALA-1000 Received notice of patent allowance from National Institute of Industrial Property Institute (INAPI), Chile , Application No. 624-2019 11 . 8 . 2022
2022/01/13 Alar Announces Significant Progress on Developing Long-acting Buprenorphine Injectable ALA-1000 14 . 1 . 2022
2020/07/22 ALA -1000 Receive notice of patent allowance from the Mexican Institute of Industrial Property (IMPI) 13 . 8 . 2020
2024/02/22 ALA-3000 has received a notice of allowance from United States Patent and Trademark Office (USPTO) after examination. (Patent Application No. 17/421,407) 29 . 2 . 2024